Contact Investor Relations

General Information

Phone: 800-258-2436 (U.S. and Canada)
+1 989-636-1000 (U.S. and Canada)

Fax: +1 989-832-1556

Investor Relations

The Dow Chemical Company
2030 Dow Center
Midland, MI 48674 U.S.A.

Phone: 800-422-8193 (U.S. and Canada)
+1 989-636-1463

Fax: +1 989-636-1830

Office of the Corporate Secretary

The Dow Chemical Company
2030 Dow Center
Midland, MI 48674 U.S.A.

Phone: +1 989-636-1792

Fax: +1 989-638-1740

Stockholder Services

General inquiries by registered stockholders may be directed to Dow's stock transfer agent:

Address written stockholder inquiries to:

P.O. Box 43006
Providence, RI 02940-3006 U.S.A.

Phone: 800-369-5606 (U.S. and Canada)

Telecommunications Devices for the Hearing Impaired (TDDs):
888-269-5221 (U.S. and Canada)

Beneficial stockholders should contact their broker directly.

Interested parties may communicate directly with the full Board, the Lead Director, the non-management Directors as a group, the Audit Committee, or with specified individual Directors by any one of several methods. These include mail addressed to The Dow Chemical Company, 2030 Dow Center, Midland, MI 48674 and by the "Contact Us" feature below. The Lead Director and other non-management Directors may also be directly contacted by email addressed to

Forward-Looking Information
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of The Dow Chemical Company and its subsidiaries (the Company). The forward-looking statements contained on this web site invoke risks and uncertainties that may affect the company's operations, markets, products, services, prices, and other factors as discussed in fillings with the U.S. Securities and Exchange Commission (SEC). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental, and technological factors. Accordingly, there is no assurance that the Company's expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.